SageMedic
John Fruehauf is a Professor of Clinical Medicine and Director of Clinical Pharmacology and Developmental Therapeutics, Chao Family Comprehensive Cancer Research Center, Univ of California, Irvine. He has an extensive track record of governmental and industry grants and cancer-related patents. Previously, John was a chemotherapy resistance research at the NCI, Chief Scientific Officer at Oncotech, developer of the extreme drug resistance assay. MD/Ph.D. from Rush University.
This person is not in any teams
This person is not in any offices
SageMedic
SageMedic uses a patient’s live biopsy to create hundreds of 3D tumor replicates in the lab so that they can identify the most effective treatment within just one week.